Parallel Session One - Tuesday 24 October 11.00 – 12.30

Global issues - The Cochrane Collaboration as an international organization

Cochrane reviews: translations help to get evidence into practice
Rachel Stancliffe, Philip Bassett, Gordon Dooley, Mark Starr

Reviews for Africa Programme (RAP): training in the science of research synthesis
Taryn Young, Paul Garner, Jimmy Volmink, Nandi Siegfried, Harriet MacLehose, Joy Oliver, Gail Kennedy

Cochrane systematic reviews in China
Maoling Wei, Ming Liu

How well are we really doing? The HIV/AIDS Mentoring Programme five years on
Alana de Kock, Nandi Siegfried, Joy Oliver, Gail Kennedy, Tara Hovarth


Presenting information in reviews and disseminating their findings

Using Cochrane reviews to identify research gaps in the perinatal evidence
Philippa Middleton, Caroline Crowther, David Henderson-Smart

Far too many excluded studies listed in Cochrane reviews
Peter Gøtzsche

High dropout rates in trials included in Cochrane reviews
Katharina Biester, Stefan Lange, Thomas Kaiser, Regine Potthast

Systematic reviews and meta-analyses fail to address bias introduced by randomized trials stopped early for benefit
Dirk Bassler, Ignacio Ferreira-González, Matthias Briel, Deborah Cook, Philip Devereaux, Diane Heels-Ansdell, Haresh Kirpalani, Maureen Meade


Searching for the evidence

Going beyond MEDLINE - what information might reviewers find from searching databases of adverse drug reactions
Su Golder, Yoon Loke, Heather McIntosh

Locating systematic reviews of healthcare interventions in children: an efficient PubMed search strategy
Nicole Boluyt, Lisa Tjosvold, Terry Klassen, Carol Lefebvre, Martin Offringa

Systematic evaluation of web-based, publicly accessible clinical trials results databases
Susan Carson, Aaron Cohen, William Hersh, Nancy Brown, Mark Helfand

A NICE Collaboration with Cochrane
Angela Melder, Andrew Cleves, Nathan Bromham, Karen Francis, Fergus MacBeth


Selective reporting

Selective reporting of outcomes of drug trials? Comparison of study protocols and published articles
Eric von Elm, Alexandra Röllin, Anette Blümle, Charles Senessie, Nicola Low, Matthias Egger

Selective reporting of the primary outcomes of clinical trials: a follow-up study
Davina Ghersi, Mike Clarke, John Simes

Reporting of adverse events in systematic reviews
Sally Hopewell, Luke Wolfenden, Mike Clarke

Under-reporting of outcomes is prevalent and inflates effect size estimates in Cochrane reviews
Toshi Furukawa, Norio Watanabe, Ichiro Omori


Statistical methods – session 1

Meta-analyses of safety data: a comparison of exact versus asymptotic methods
Ben Vandermeer, Liza Bialy, Brad Johnston, Nicola Hooton, Lisa Hartling, Terry Klassen, Natasha Wiebe

Appropriateness of asymmetry tests for publication bias in meta-analysis: large-scale survey
John Ioannidis, Thomas Trikalinos

Evaluating two statistical methods to predict when a meta-analysis will gain sufficient power to change the conclusions of a Cochrane review
Alex Sutton, Carrol Gamble, Sarah Donegan, Paul Garner

A novel approach to mixed-treatment meta-analyses
Ian Shrier, Russell Steele, Robert Platt


Study quality

Factors associated with results and conclusions of drug-drug comparisons: or why some statins appear more efficacious than others
Lisa Bero, Fieke Oostvogel, Kirby Lee

Adjustment of meta-analyses on the basis of quality score ranking should be abandoned
William Gillespie, Peter Herbison, Jean Hay-Smith

The association of allocation concealment and blinding with estimated treatment effect varies according to type of outcome: a combined analysis of meta-epidemiological studies
Lesley Wood, Matthias Egger, Lise Lotte Gluud, Kenneth Schulz, Douglas Altman, Peter Jüni, Jonathan Sterne

Investigation of authenticity of 'claimed' randomized controlled trials (RCTs) and quality assessment of RCT reports published in China
Taixiang Wu, Youping Li, Guanjian Liu, Zhaoxiang Bian, Jing Li, Jing Zhang, Lingxia Xie, Juan Ni